Neuromodulatory Signaling in Chronic Pain Patients: A Narrative Review

Area of Science:

• Neuroscience
• Pain Research
• Pharmacology

Background:

• Chronic pain pathophysiology involves sustained nociceptive input, neuroplasticity, and neuroimmune interactions.
• Dysregulation of neuromodulatory pathways (neurotransmitters, neuropeptides, neurotrophic factors) contributes to pain chronification.
• Neuroinflammation and altered monoaminergic transmission are implicated in conditions like fibromyalgia, reducing treatment efficacy.

Purpose of the Study:

• To review the role of neuromodulatory systems in chronic pain.
• To explore synaptic plasticity, nociceptor sensitization, and neuroimmune crosstalk in pain.
• To propose a mechanistic framework for pain chronification and therapeutic targeting.

Main Methods:

• Synthesis of current evidence from preclinical and clinical studies.
• Focus on neuromodulatory systems, including neurotransmitters, neuropeptides, and neurotrophic factors.
• Integration of findings from transcriptomic profiling, neuroimaging, and single-cell RNA sequencing.

Main Results:

• Neuromodulatory circuit dysregulation underlies diverse chronic pain phenotypes.
• Patient-specific patterns of dysfunction identified through advanced technologies.
• Potential biomarkers for disease stratification and targeted therapies highlighted.

Conclusions:

• Dysregulated neuromodulatory circuits are key to chronic pain.
• Precision medicine approaches targeting these circuits show promise.
• Pharmacological and neuromodulation technologies offer personalized pain management strategies.